Xtant Medical Holdings, Inc.
AMEX:XTNTMedical - Devices
-$0.00 today
- Market cap
- $50.37M
- Beta
- -0.17
- P/E (TTM)
- 33.4
- EPS (TTM)
- $0.01
Volume 0.16M
Average 0.16M
XTNT Total Debt
Short-term and long-term borrowings combined.
Xtant Medical Holdings, Inc.AMEX: XTNT
Total Debt · Q1 FY2026 · quarter ended Mar 2026
Total debt falls 55.0% from a year ago
Total debt stood at $15.44M at the end of Q1 FY2026, down 55.0% from a year earlier and down 46.2% from the prior quarter. Over 3 fiscal years it compounded at +18.9% a year.
Context
- Total debt amounted to 19.8% of total assets at the end of Q1 FY2026, down 16.0 pp from a year earlier.
- Total debt increased in 2 of the last 3 fiscal years.
What to watch
Whether total debt keeps falling in the next quarterly balance sheet after a -55.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Debt history
USD · from the balance sheet
- Latest · FY2025
- 28.72M USD
- Year-over-year change
- -18.3%
- 4-year CAGR
- +14.3%
| Period | Period end | Total Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 28.72M | -18.3% |
| FY2024 | 2024-12-31 | 35.14M | +49.2% |
| FY2023 | 2023-12-31 | 23.56M | +38.0% |
| FY2022 | 2022-12-31 | 17.07M | +1.3% |
| FY2021 | 2021-12-31 | 16.85M | — |
Total Debt vs competitors
How XTNT compares with its peers on the latest reported figures
- XTNT's Mar 2026 total debt of $15.44M is the 6th highest of the 8 companies compared; the peer median is $23.71M.
- Its year-over-year change of -55.0% is the 7th highest of 8, against a peer median of -3.5%.
- Total debt amounts to 19.8% of total assets for XTNT, versus a peer median of 38.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $39.46M | +1.4% | +267.0% | 62.6% | |
| Mar 2026 | $38.83M | -2.4% | +0.6% | 17.7% | |
| Mar 2026 | $26.8M | -24.0% | +134.6% | 78.6% | |
| Mar 2026 | $23.71M | +303.5% | +44.2% | 38.0% | |
| Mar 2026 | $18.28M | -3.5% | +170.3% | 43.1% | |
| Mar 2026 | $15.44M | -55.0% | +18.9% | 19.8% | |
| Mar 2026 | $1.98M | -95.5% | +268.8% | 3.8% | |
EXOZeXoZymes, Inc. | Mar 2026 | $1.16M | -12.2% | +26.9% | 29.0% |
| Peer median (excluding XTNT) | $23.71M | -3.5% | +134.6% | 38.0% | |
Competitors are the stored peer set for XTNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 18.24M | 20.3M | 5.72M | 6.2M | 17.05M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 7.15M | 10.85M | 20.73M | 20.66M | 17.8M |
| Inventory | 17.95M | 17.29M | 36.89M | 38.63M | 30.26M |
| Other Current Assets | 144K | 882K | 1.54M | 1.62M | 13.13M |
| Total Current Assets | 44.33M | 49.32M | 64.87M | 67.12M | 78.25M |
| Property, Plant & Equipment (Net) | 6.47M | 7.17M | 10.22M | 10.96M | 9.39M |
| Goodwill | 3.21M | 3.21M | 7.3M | 7.3M | 6.07M |
| Intangible Assets | 400K | 344K | 10.09M | 8.36M | 299K |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 287K | 197K | 141K | 103K | 133K |
| Total Non-current Assets | 10.36M | 10.91M | 27.74M | 26.72M | 15.9M |
| Total Assets | 54.69M | 60.23M | 92.61M | 93.84M | 94.15M |
| Account Payables | 2.62M | 3.49M | 7.05M | 7.92M | 3.84M |
| Short-term Debt | 3.62M | 5.71M | 4.62M | 12.12M | 14.36M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.18M | 4.46M | 0 | 5.57M | 0 |
| Total Current Liabilities | 11.08M | 15.22M | 22.99M | 28.58M | 29.48M |
| Long-term Debt | 11.79M | 9.69M | 17.17M | 22.04M | 11.03M |
| Deferred Tax Liabilities | 0 | 0 | 21K | 42K | 5K |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 210K | 0 | 0 |
| Total Non-current Liabilities | 12.73M | 10.84M | 18.27M | 22.29M | 13.71M |
| Total Liabilities | 23.81M | 26.06M | 41.26M | 50.87M | 43.19M |
| Common Stock | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | (235.19M) | (243.67M) | (243.01M) | (259.46M) | (254.49M) |
| Accumulated OCI | 0 | 0 | 29K | (316K) | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 30.88M | 34.17M | 51.35M | 42.96M | 50.95M |
| Total Debt | 16.85M | 17.07M | 23.56M | 35.14M | 28.72M |
| Net Debt | (1.4M) | (3.23M) | 17.84M | 28.94M | 11.66M |
Xtant Medical Holdings, Inc.
AMEX:XTNT
Intrinsic Alpha fair value
Locked
Current Price
$0.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.